Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients

Table 3

Correlation of clinical/echocardiographic parameters with log-transformed ST2 and diastolic dysfunction.

Log-transformed ST2	Correlation coefficient
BMI	0.21	.056
SBP	0.127	.237
DBP	0.03	.981
PP	0.178	.097
MAP	0.071	.509
CVAR	0.253	.023
Ascending aorta	0.212	.048
Left atrium area	0.16	.21
End-diastolic interventricular septum	0.51	.000
End-diastolic LV posterior wall	0.40	.03
End-diastolic LV size	0.28	.02
End-systolic LV size	0.35	.01
LV mass index	0.44	.000
Ejection fraction	0.119	.268
E/A	0.22	.03
E/e’m	0.215	.02
Ejection time	−0.259	.015
Diastolic dysfunction	Correlation coefficient	p
Ascending aorta	0.212	.048
Left atrium area	0.16	.21
End-diastolic interventricular septum	0.51	.000
End-diastolic LV posterior wall	0.40	.03
End-diastolic LV size	0.28	.02
End-systolic LV size	0.35	.01
LV mass index	0.44	.000
Peak E/A ratio	0.22	.03
Myocardial performance index	0.245	.012
ST2	0.273	.006
E/e’m	0.547	.000
Ejection time	0.235	.015

HBP: hypertension; LVH: left ventricular hypertrophy; SBP: systolic blood pressure; DBP: diastolic blood pressure; PP: pulse pressure; MAP: mean arterial pressure; BMI: body mass index; LV: left ventricle; CVAR: cardiovascular additional risk; A: late diastolic mitral peak filling velocity; E: early diastolic mitral peak filling velocity; e’m: peak early diastolic mitral annulus velocity by tissue Doppler.